Do European pharmacists really have to trespass on medicine?
Author
Abstract
Suggested Citation
DOI: 10.1007/s10198-020-01185-w
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Livio Garattini & Alessandro Curto & Anna Padula, 2016. "Reimbursable drug classes and ceilings in Italy: why not only one?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 923-926, November.
- Livio Garattini & Anna Padula, 2018. "Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?," PharmacoEconomics - Open, Springer, vol. 2(3), pages 221-224, September.
- Santuari, Alceste, 2017. "Legal and organisational innovation in the Italian pharmacy system: commercial vs public interest," Health Economics, Policy and Law, Cambridge University Press, vol. 12(4), pages 495-513, October.
Citations
Blog mentions
As found by EconAcademics.org, the blog aggregator for Economics research:- Rita Faria’s journal round-up for 8th February 2021
by Rita Faria in The Academic Health Economists' Blog on 2021-02-08 12:00:01
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Kališ, Richard, 2024. "From symbiosis to independence: Investigating changes in the relationship between general practitioners’ presence and pharmacies’ market size in Slovakia," Health Policy, Elsevier, vol. 143(C).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Sheema Matloob & Zohra Bhatti & Hasliza Abdul Halim & Raja Sikander, 2018. "Delving into the Impact of Job Match and Remuneration on Burnout and Turnover Intention among Pharmacists in Pakistan," International Journal of Academic Research in Business and Social Sciences, Human Resource Management Academic Research Society, International Journal of Academic Research in Business and Social Sciences, vol. 8(6), pages 898-911, June.
- Livio Garattini & Anna Padula, 2018. "Pharmaceutical pricing conundrum: time to get rid of it?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(8), pages 1035-1038, November.
- Lucia Leporatti & Rosella Levaggi & Marcello Montefiori, 2021. "Beyond price: the effects of non-financial barriers on access to drugs and health outcomes," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 519-529, June.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:22:y:2021:i:1:d:10.1007_s10198-020-01185-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.